These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 14569416)

  • 21. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
    Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
    Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
    Zhao Y; Zong ZH; Xu HM
    Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma.
    Mitsuhashi N; Shimizu H; Ohtsuka M; Wakabayashi Y; Ito H; Kimura F; Yoshidome H; Kato A; Nukui Y; Miyazaki M
    Hepatology; 2003 May; 37(5):1105-13. PubMed ID: 12717391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
    Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
    Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
    Cao Y; Sonveaux P; Liu S; Zhao Y; Mi J; Clary BM; Li CY; Kontos CD; Dewhirst MW
    Cancer Res; 2007 Apr; 67(8):3835-44. PubMed ID: 17440098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia up-regulates the effects of prostaglandin E2 on tumor angiogenesis in ovarian cancer cells.
    Zhu G; Saed GM; Deppe G; Diamond MP; Munkarah AR
    Gynecol Oncol; 2004 Aug; 94(2):422-6. PubMed ID: 15297183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
    Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
    Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expressions of canine angiopoietin-1 and -2 in normal tissues and spontaneous tumours.
    Kato Y; Asano K; Mizutani I; Konno T; Sasaki Y; Kutara K; Teshima K; Edamura K; Kano R; Suzuki K; Shibuya H; Sato T; Hasegawa A; Tanaka S
    Res Vet Sci; 2006 Oct; 81(2):280-6. PubMed ID: 16545849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
    Van der Auwera I; Van Laere SJ; Van den Eynden GG; Benoy I; van Dam P; Colpaert CG; Fox SB; Turley H; Harris AL; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Dec; 10(23):7965-71. PubMed ID: 15585631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma.
    Emoto M; Charnock-Jones DS; Licence DR; Ishiguro M; Kawai M; Yanaihara A; Saito T; Hachisuga T; Iwasaki H; Kawarabayashi T; Smith SK
    Gynecol Oncol; 2004 Dec; 95(3):474-82. PubMed ID: 15581949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
    Stoeltzing O; Ahmad SA; Liu W; McCarty MF; Wey JS; Parikh AA; Fan F; Reinmuth N; Kawaguchi M; Bucana CD; Ellis LM
    Cancer Res; 2003 Jun; 63(12):3370-7. PubMed ID: 12810673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The selection of taxol resistance associated genes in ovarian cancer cell line by mRNA DD].
    Cheng G; Tian F; Li Y
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):541-3. PubMed ID: 11798816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1.
    Ye L; Haider HKh; Jiang S; Ge R; Law PK; Sim EK
    J Heart Lung Transplant; 2005 Sep; 24(9):1393-402. PubMed ID: 16143262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR; Song WJ; Chen ZM; Wu QH
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiopoietin-2 inhibits the growth of tongue carcinoma without affecting expression of vascular endothelial growth factor.
    Chen HH; Chai L; Wang SQ; Shi ZJ; Wu QL
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):628-32. PubMed ID: 21163623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
    Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
    Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
    Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.